PCSK9 inhibition-mediated reduction in Lp(a) with evolocumab: an analysis of 10 clinical trials and the LDL receptor's role (Q36930207)
Jump to navigation
Jump to search
scientific article published on 21 April 2016
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | PCSK9 inhibition-mediated reduction in Lp(a) with evolocumab: an analysis of 10 clinical trials and the LDL receptor's role |
scientific article published on 21 April 2016 |
Statements
1 reference
PCSK9 inhibition-mediated reduction in Lp(a) with evolocumab: an analysis of 10 clinical trials and the LDL receptor's role (English)
1 reference
Frederick J Raal
1 reference
Marc S Sabatine
1 reference
Michael J Koren
1 reference
Dirk Blom
1 reference
Narimon Honarpour
1 reference
Armando Lira
1 reference
Allen Xue
1 reference
Padmaja Chiruvolu
1 reference
Simon Jackson
1 reference
Mei Di
1 reference
Matthew Peach
1 reference
Ransi Somaratne
1 reference
Scott M Wasserman
1 reference
Rob Scott
1 reference
Evan A Stein
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
Identifiers
1 reference